Jung ST - Search Results

1

A human antibody against human endothelin receptor type A that exhibits antitumor potency.

Ju MS, Ahn HM, Han SG, Ko S, Na JH, Jo M, Lim CS, Ko BJ, Yu YG, Lee WK, Kim YJ, Jung ST. Ju MS, et al. Among authors: jung st. Exp Mol Med. 2021 Sep;53(9):1437-1448. doi: 10.1038/s12276-021-00678-9. Epub 2021 Sep 29. Exp Mol Med. 2021. PMID: 34588605 Free PMC article.

2

Engineering therapeutic antibodies targeting G-protein-coupled receptors.

Jo M, Jung ST. Jo M, et al. Among authors: jung st. Exp Mol Med. 2016 Feb 5;48(2):e207. doi: 10.1038/emm.2015.105. Exp Mol Med. 2016. PMID: 26846450 Free PMC article. Review.

3

Engineered aglycosylated full-length IgG Fc variants exhibiting improved FcγRIIIa binding and tumor cell clearance.

Jo M, Kwon HS, Lee KH, Lee JC, Jung ST. Jo M, et al. Among authors: jung st. MAbs. 2018 Feb/Mar;10(2):278-289. doi: 10.1080/19420862.2017.1402995. Epub 2017 Dec 7. MAbs. 2018. PMID: 29173039 Free PMC article.

4

Engineered Arabidopsis Blue Light Receptor LOV Domain Variants with Improved Quantum Yield, Brightness, and Thermostability.

Ko S, Hwang B, Na JH, Lee J, Jung ST. Ko S, et al. Among authors: jung st. J Agric Food Chem. 2019 Oct 30;67(43):12037-12043. doi: 10.1021/acs.jafc.9b05473. Epub 2019 Oct 17. J Agric Food Chem. 2019. PMID: 31581772

5

Discovery of Novel Pseudomonas putida Flavin-Binding Fluorescent Protein Variants with Significantly Improved Quantum Yield.

Ko S, Jeon H, Yoon S, Kyung M, Yun H, Na JH, Jung ST. Ko S, et al. Among authors: jung st. J Agric Food Chem. 2020 May 27;68(21):5873-5879. doi: 10.1021/acs.jafc.0c00121. Epub 2020 May 13. J Agric Food Chem. 2020. PMID: 32367716

6

Engineered human FcγRIIa fusion: A novel strategy to extend serum half-life of therapeutic proteins.

Jo M, Ko S, Hwang B, Min SW, Ha JY, Lee JC, Jang SE, Jung ST. Jo M, et al. Among authors: jung st. Biotechnol Bioeng. 2020 Aug;117(8):2351-2361. doi: 10.1002/bit.27374. Epub 2020 May 16. Biotechnol Bioeng. 2020. PMID: 32369186

7

Antigen Design for Successful Isolation of Highly Challenging Therapeutic Anti-GPCR Antibodies.

Ju MS, Jung ST. Ju MS, et al. Among authors: jung st. Int J Mol Sci. 2020 Nov 3;21(21):8240. doi: 10.3390/ijms21218240. Int J Mol Sci. 2020. PMID: 33153215 Free PMC article. Review.

8

Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies Through Fc Engineering.

Ko S, Jo M, Jung ST. Ko S, et al. Among authors: jung st. BioDrugs. 2021 Mar;35(2):147-157. doi: 10.1007/s40259-021-00471-0. Epub 2021 Feb 19. BioDrugs. 2021. PMID: 33608823 Free PMC article. Review.

9

A short PEG linker alters the in vivo pharmacokinetics of trastuzumab to yield high-contrast immuno-PET images.

Lee W, Bobba KN, Kim JY, Park H, Bhise A, Kim W, Lee K, Rajkumar S, Nam B, Lee KC, Lee SH, Ko S, Lee HJ, Jung ST, Yoo J. Lee W, et al. Among authors: jung st. J Mater Chem B. 2021 Apr 7;9(13):2993-2997. doi: 10.1039/d0tb02911d. Epub 2021 Mar 16. J Mater Chem B. 2021. PMID: 33725072

10

Correction: A short PEG linker alters the in vivo pharmacokinetics of trastuzumab to yield high-contrast immuno-PET images.

Lee W, Bobba KN, Kim JY, Park H, Bhise A, Kim W, Lee K, Rajkumar S, Nam B, Lee KC, Lee SH, Ko S, Lee HJ, Jung ST, Yoo J. Lee W, et al. Among authors: jung st. J Mater Chem B. 2021 Aug 4;9(30):6092. doi: 10.1039/d1tb90111g. J Mater Chem B. 2021. PMID: 34312646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters